ENZ Insider Trading
ENZ | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at ENZ provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2023-02-14 05:41 | 2023-02-10 | Wolf James G. | Other | BUY | $1.29 | 15,000 | $19,325 | 115,000 | +15.0% |
| 2023-01-30 20:01 | 2023-01-27 | Wolf James G. | 10% owner | BUY | $1.40 | 11,800 | $16,520 | 4,090,000 | +0.3% |
| 2023-01-19 22:37 | 2022-10-31 | Wolf James G. | 10% owner | BUY | $2.15 | 23,000 | $49,399 | 418,500 | +5.8% |
| 2022-11-29 02:27 | 2022-11-23 | Erfanian Hamid | Director, Officer - Chief Executive Officer | BUY | $1.97 | 100,000 | $197,000 | 374,600 | +36.4% |
| 2022-07-20 00:30 | 2022-07-15 | Cannon Kara | Officer - Chief Operating Officer | BUY | $2.42 | 2,500 | $6,050 | 2,500 | +100.0% |
| 2022-07-13 14:00 | 2022-07-12 | Radoff Bradley Louis | Director | BUY | $2.27 | 12,500 | $28,375 | 4,194,663 | +0.3% |
| 2022-07-06 23:30 | 2022-07-05 | Radoff Bradley Louis | Director | BUY | $2.20 | 120,000 | $264,000 | 4,182,163 | +3.0% |
| 2022-06-17 23:31 | 2022-06-15 | Erfanian Hamid | Officer - Chief Executive Officer | BUY | $2.19 | 4,600 | $10,074 | 274,600 | +1.7% |
| 2022-06-17 03:29 | 2022-06-15 | Radoff Bradley Louis | Director | BUY | $2.20 | 125,000 | $275,500 | 3,987,163 | +3.2% |
| 2022-06-15 23:31 | 2022-06-14 | Bench David | Officer - Chief Financial Officer | BUY | $2.15 | 3,500 | $7,525 | 6,000 | +140.0% |
| 2021-03-18 00:28 | 2021-03-15 | HARBERT MANAGEMENT CORP | 10% owner | SELL | $4.71 | 444,768 | $2,092,722 | 5,175,913 | -7.9% |
| 2020-02-19 22:45 | 2020-02-14 | CLEMENS PETER J IV | 10% owner | BUY | $2.21 | 10,000 | $22,060 | 15,000 | +200.0% |
| 2019-08-21 00:44 | 2019-08-16 | HARBERT MANAGEMENT CORP | 10% owner | BUY | $3.07 | 32,500 | $99,934 | 5,620,681 | +0.6% |
| 2019-07-24 19:21 | 2019-07-22 | HARBERT MANAGEMENT CORP | 10% owner | BUY | $3.65 | 418,844 | $1,528,697 | 5,588,181 | +8.1% |
| 2019-05-31 00:20 | 2019-05-28 | HARBERT MANAGEMENT CORP | 10% owner | BUY | $3.09 | 102,118 | $315,054 | 5,169,337 | +2.0% |
| 2019-05-22 23:49 | 2019-05-20 | HARBERT MANAGEMENT CORP | 10% owner | BUY | $3.61 | 14,132 | $51,017 | 5,067,219 | +0.3% |
| 2018-10-31 16:06 | 2018-10-29 | RABBANI ELAZAR | Director, Officer - Chm of the Bd, CEO and Sec | BUY | $3.35 | 10,000 | $33,469 | 1,848,668 | +0.5% |
| 2018-10-22 19:48 | 2018-10-18 | Perlysky Dov | Director | BUY | $3.50 | 10,000 | $35,000 | 266,235 | +3.9% |
| 2018-10-22 16:00 | 2018-10-18 | Hanna Bruce A. | Director | BUY | $3.52 | 15,000 | $52,787 | 37,816 | +65.7% |
| 2018-01-20 00:43 | 2018-01-17 | WEINER BARRY W | Officer - President, CFO, Treasurer, PAO | OPT+S | $7.75 | 11,000 | $85,250 | 1,302,111 | 0.0% |
| 2018-01-20 00:42 | 2018-01-17 | RABBANI ELAZAR | Director, Officer - CEO, Chn. of the Brd. and Sec. | OPT+S | $7.75 | 14,000 | $108,500 | 1,853,202 | 0.0% |
| 2017-11-03 03:00 | 2017-10-31 | Perlysky Dov | Director | OPT+S | $9.81 | 42,000 | $412,020 | 642,237 | 0.0% |
| 2017-11-03 03:00 | 2017-10-31 | BORTZ GREGORY M. | Director | OPT+S | $9.82 | 42,005 | $412,489 | 250,870 | 0.0% |
| 2017-10-31 04:18 | 2017-10-27 | O'Brien James Michael | Officer - EVP of Finance | OPT+S | $10.28 | 22,866 | $235,062 | 28,187 | 0.0% |
| 2017-10-28 00:06 | 2017-10-25 | WEINER BARRY W | Director, Officer - President, CFO, Treasurer, PAO | OPT+S | $10.11 | 54,126 | $547,214 | 1,369,241 | 0.0% |
| 2017-10-28 00:05 | 2017-10-25 | RABBANI ELAZAR | Director, Officer - CEO, Chn. of the Brd. and Sec. | OPT+S | $10.09 | 72,401 | $730,526 | 1,966,073 | 0.0% |
| 2017-06-16 00:10 | 2017-06-13 | O'Brien James Michael | Officer - EVP of Finance | OPT+S | $10.13 | 15,800 | $160,054 | 15,800 | 0.0% |
| 2016-03-18 21:41 | 2016-01-21 | KASTEN BERNARD L | Director | SELL | $4.01 | 42,782 | $171,466 | 0 | -100.0% |
| 2014-11-14 00:07 | 2014-10-23 | KASTEN BERNARD L | Director | SELL | $4.93 | 15,900 | $78,463 | 42,782 | -27.1% |
| 2011-11-18 16:48 | 2011-11-16 | RABBANI ELAZAR | Director, Officer - CEO and Secretary | BUY | $2.29 | 20,000 | $45,718 | 2,120,289 | +1.0% |
| 2011-11-17 19:49 | 2011-11-16 | WEINER BARRY W | Director, Officer - Pres, CFO, Princ AO and Treasr | BUY | $2.29 | 20,000 | $45,724 | 1,312,206 | +1.5% |
| 2010-12-21 02:13 | 2010-12-15 | BALEZENTIS CARL W | Officer - Pres., Enzo Life Sciences | SELL | $5.12 | 12,724 | $65,147 | 25,950 | -32.9% |
| 2010-10-27 01:53 | 2010-10-22 | Kent Stephen B H | Director | SELL | $4.30 | 8,000 | $34,432 | 9,654 | -45.3% |
| 2010-08-07 02:17 | 2010-08-05 | Kent Stephen B H | Director | SELL | $4.47 | 2,500 | $11,179 | 17,654 | -12.4% |
| 2010-07-02 17:37 | 2010-04-07 | BALEZENTIS CARL W | Officer - Pres., Enzo Life Sciences | SELL | $6.23 | 30 | $187 | 35,724 | -0.1% |
| 2010-06-16 18:14 | 2010-06-11 | Kent Stephen B H | Director | SELL | $4.29 | 5,000 | $21,471 | 20,154 | -19.9% |
| 2010-03-29 22:51 | 2010-03-15 | Kent Stephen B H | Director | SELL | $6.15 | 5,000 | $30,742 | 25,154 | -16.6% |
| 2009-10-19 23:05 | 2009-10-15 | KRENITSKY KEVIN | Officer - President, Enzo Clinical Labs | BUY | $7.70 | 6,600 | $50,828 | 6,600 | +100.0% |
| 2008-11-05 02:11 | 2008-10-30 | BALEZENTIS CARL W | Officer - President, Enzo Life Sciences | SELL | $5.35 | 580 | $3,103 | 4,420 | -11.6% |
| 2008-11-04 03:22 | 2008-10-30 | BALEZENTIS CARL W | Officer - President, Enzo Life Sciences | SELL | $5.35 | 580 | $3,103 | 4,650 | -11.1% |
| 2008-07-23 01:49 | 2008-07-18 | RABBANI SHAHRAM K | Director, Officer - Treasurer, Secretary | BUY | $13.31 | 82,645 | $1,100,005 | 1,828,494 | +4.7% |
| 2008-02-07 03:35 | 2008-02-05 | Kent Stephen B H | Director | SELL | $10.16 | 3,500 | $35,568 | 0 | -100.0% |
| 2007-12-22 00:04 | 2007-12-20 | KELKER NORMAN E | Officer - Senior Vice President | SELL | $12.75 | 13,600 | $173,442 | 104,583 | -11.5% |
| 2007-12-21 05:29 | 2007-12-19 | RABBANI SHAHRAM K | Director, Officer - Treasurer, Secretary | SELL | $13.07 | 134,397 | $1,756,717 | 2,056,538 | -6.1% |
| 2007-10-31 03:42 | 2007-10-26 | THALENFELD BARBARA E | Officer - VP, Corporate Development | SELL | $12.48 | 10,376 | $129,492 | 60,813 | -14.6% |
| 2007-10-20 04:12 | 2007-10-17 | RABBANI SHAHRAM K | Director, Officer - Treasurer and Secretary | SELL | $13.05 | 108,100 | $1,410,943 | 2,081,640 | -4.9% |
| 2005-07-20 18:27 | 2005-07-19 | KELKER NORMAN E | Officer - Senior Vice President | SELL | $16.60 | 10,000 | $166,003 | 114,283 | -8.0% |
| 2005-07-13 00:16 | 2005-07-11 | THALENFELD BARBARA E | Officer - Vice President, Corporate Deve | SELL | $17.80 | 3,570 | $63,546 | 14,876 | -19.4% |
| 2005-02-19 00:56 | 2005-02-04 | ENGELHARDT DEAN | Officer - Executive Vice President | SELL | $18.81 | 5,154 | $96,949 | 153,651 | -3.2% |
| 2005-02-05 00:37 | 2005-02-03 | ENGELHARDT DEAN | Officer - Executive Vice President | SELL | $18.28 | 5,000 | $91,414 | 158,805 | -3.1% |
How to Interpret $ENZ Trades
Not every insider transaction in ENZ is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ENZ shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ENZ
Insider activity data for ENZ is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ENZ, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.